ANG Lifesciences India Limited (BOM:540694)
37.78
+1.62 (4.48%)
At close: Oct 16, 2026
ANG Lifesciences India Revenue
ANG Lifesciences India had revenue of 152.98M INR in the quarter ending June 30, 2026, a decrease of -37.82%. This brings the company's revenue in the last twelve months to 835.87M, down -15.60% year-over-year. In the fiscal year ending March 31, 2026, ANG Lifesciences India had annual revenue of 928.93M with 0.05% growth. That makes ANG Lifesciences India the 37,907th largest company in the world by revenue and 3,356th in India.
Revenue (ttm)
835.87M
Revenue Growth
-15.60%
P/S Ratio
0.59
Revenue / Employee
2.21M
Employees
379
Market Cap
493.34M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 928.93M | 461.00K | 0.05% |
| Mar 31, 2025 | 928.47M | -532.63M | -36.45% |
| Mar 31, 2024 | 1.46B | -737.81M | -33.55% |
| Mar 31, 2023 | 2.20B | -1.34B | -37.94% |
| Mar 31, 2022 | 3.54B | 2.00B | 129.50% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Murae Organisor | 8.59B |
| Mangalam Drugs & Organics | 2.32B |
| Rajnish Wellness | 1.68B |
| JFL Life Sciences | 1.31B |
| Sandu Pharmaceuticals | 696.24M |
| Onyx Biotec | 694.69M |
| Phaarmasia | 486.17M |
| Biofil Chemicals and Pharmaceuticals | 346.26M |